SECUKINUMAB SIGNFICANTLY IMPROVES THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS IN PATIENTS PREVIOUSLY EXPOSED TO ANTI-TUMOUR NECROSIS FACTOR THERAPY AND ANTI-TUMOUR NECROSIS FACTOR-NAIVE PATIENTS: 52 WEEK RESULTS FROM THE PHASE III FUTURE 2 TRIAL

被引：0
|
作者：
McInnes, Iain [1 ]
Chinoy, Hector [2 ]
Kavanaugh, Arthur [3 ]
Wang, Zailong [4 ]
Mpofu, Shephard [5 ]
机构：
[1] Univ Glasgow, Infect Immun & Inflammat, Glasgow, Lanark, Scotland
[2] Univ Manchester, Musculoskeletal Res Inflammat & Repair, Manchester, Lancs, England
[3] Univ Calif San Diego, Sch Med, Innovat Therapy, San Diego, CA 92103 USA
[4] Nova Pharmaceut Corp, Stat, E Hanover, NJ USA
[5] Novartis Pharmaceut, Clin Dev, Basel, Switzerland
来源：
RHEUMATOLOGY | 2016年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
195
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [1] The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
    Harrold, Leslie R.
    Reed, George W.
    Kremer, Joel M.
    Curtis, Jeffrey R.
    Solomon, Daniel H.
    Hochberg, Marc C.
    Greenberg, Jeffrey D.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) : 430 - 436
  • [2] Secukinumab after anti-tumour necrosis factor- therapy: a phase III study in active rheumatoid arthritis
    Dokoupilova, E.
    Aelion, J.
    Takeuchi, T.
    Malavolta, N.
    Sfikakis, P. P.
    Wang, Y.
    Rohrer, S.
    Richards, H. B.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (04) : 276 - 281
  • [3] Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-α therapy
    Rosner, I.
    Haddad, A.
    Boulman, N.
    Feld, J.
    Avshovich, N.
    Slobodin, G.
    Rozenbaum, M.
    RHEUMATOLOGY, 2007, 46 (09) : 1508 - 1508
  • [4] Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-α therapy
    Roux, C. H.
    Brocq, O.
    Breuil, V.
    Albert, C.
    Euller-Ziegler, L.
    RHEUMATOLOGY, 2007, 46 (04) : 695 - 698
  • [5] Anti-tumour necrosis factor treatment in HIV-positive patients with psoriatic arthritis
    Cobo Ibanez, Tatiana
    Zamora, Francisco
    Herranz, Pedro
    Steiner, Martina
    MEDICINA CLINICA, 2009, 133 (17): : 682 - 683
  • [6] Impact of anti-tumour necrosis factor therapy on the weight of patients with rheumatoid arthritis
    Alcorn, Nicola
    Tierney, Ann
    Wu, Olivia
    Gilmour, Harper
    Madhok, Rajan
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (08) : 1571 - 1571
  • [7] Anti-tumour necrosis factor α therapy modulates ghrelin in patients with severe rheumatoid arthritis
    Gonzalez-Gay, M. A.
    Garcia-Unzueta, M. T.
    Berja, A.
    Vazquez-Rodriguez, T. R.
    Gonzalez-Juanatey, C.
    de Matias, J. M.
    Martin, J.
    Dessein, P. H.
    Llorca, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (11) : 1644 - 1646
  • [8] DRUG SURVIVAL OF SECOND BIOLOGIC DMARD THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: COMPARISON OF A SECOND ANTI-TUMOUR NECROSIS FACTOR WITH A SECOND NON-ANTI-TUMOUR NECROSIS FACTOR AFTER DISCONTINUATION OF A FIRST ANTI-TUMOUR NECROSIS FACTOR
    Wilke, Thomas
    Mueller, Sabrina
    Majer, Istvan
    Heisen, Marieke
    Fuchs, Andreas
    Maywald, Ulf
    RHEUMATOLOGY, 2016, 55 : 105 - 105
  • [9] Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis
    Popa, C
    Netea, MG
    Radstake, T
    Van der Meer, JWM
    Stalenhoef, AFH
    van Riel, PLCM
    Barerra, P
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) : 303 - 305
  • [10] Anti-tumour necrosis factor alpha therapy normalises fibrinolysis impairment in patients with active rheumatoid arthritis
    Ingegnoli, F.
    Fantini, F.
    Griffini, S.
    Soldi, A.
    Meroni, P. L.
    Cugno, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : 254 - 257
12345